Carson Wealth (CWM LLC)’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$104K Buy
4,364
+1,898
+77% +$52.7K ﹤0.01% 3234
2025
Q4
$68K Buy
2,466
+329
+15% +$8.39K ﹤0.01% 3374
2025
Q3
$52K Buy
2,137
+96
+5% +$1.91K ﹤0.01% 3495
2025
Q2
$35K Sell
2,041
-643
-24% -$11.2K ﹤0.01% 3525
2025
Q1
$52K Buy
2,684
+1,191
+80% +$31.2K ﹤0.01% 2948
2024
Q4
$37K Buy
1,493
+5
+0.3% +$128 ﹤0.01% 2998
2024
Q3
$36K Sell
1,488
-27
-2% -$698 ﹤0.01% 2943
2024
Q2
$35K Sell
1,515
-31
-2% -$761 ﹤0.01% 2715
2024
Q1
$51K Sell
1,546
-205
-12% -$6.39K ﹤0.01% 2285
2023
Q4
$48K Sell
1,751
-235
-12% -$5.84K ﹤0.01% 2200
2023
Q3
$48K Sell
1,986
-25,456
-93% -$682K ﹤0.01% 2083
2023
Q2
$876K Sell
27,442
-1,145
-4% -$37.2K 0.01% 757
2023
Q1
$875K Sell
28,587
-1,301
-4% -$51.3K 0.01% 695
2022
Q4
$1.17M Sell
29,888
-5,859
-16% -$262K 0.01% 569
2022
Q3
$1.7M Sell
35,747
-1,165
-3% -$66.5K 0.01% 442
2022
Q2
$1.43M Buy
36,912
+36,894
+204,967% +$1.47M 0.01% 466
2022
Q1
$1K Buy
+18
New +$1.18K ﹤0.01% 3298

Other funds holding BEAM

Carson Wealth (CWM LLC)'s BEAM Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Beam Therapeutics (BEAM) stake by 77% in Q1 2026, buying an estimated $52.7K and bringing the position to 4,364 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #3234.

Carson Wealth (CWM LLC) first reported a position in BEAM in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.7M in Q3 2022. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Carson Wealth (CWM LLC) held 4,364 shares of Beam Therapeutics worth $104K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 1,898 Beam Therapeutics shares in Q1 2026, an estimated $52.7K.
  • Beam Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3234 holding.
  • Carson Wealth (CWM LLC) first reported a position in Beam Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Carson Wealth (CWM LLC)'s Beam Therapeutics position peaked at $1.7M in Q3 2022.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.